SYK

In the past six months, Stryker Corp.'s stock price declined by approximately 22% over 30 days leading up to early September 2026, falling to near 52-week lows. Over the last 12 months, the stock decreased by 22.95%, with a year-to-date return of -18.72%. Key events impacting the stock include persistent supply chain disruptions in its peripheral vascular business, softer-than-expected summer seasonality in joint replacements, a cyberattack affecting procedure volumes, and an orderly leadership transition in October 2026 where CEO Kevin Lobo became Executive Chair and Spencer Stiles took over as CEO in January 2027. Additionally, several analysts trimmed price targets following company commentary at a healthcare conference.